GLP-1 receptor agonists prove effective for kidney and cardiovascular outcomes

The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without diabetes.

Acelyrin sheds pipeline, lays off 33% of staff three months after CEO departure

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 14, 2024

Laguna Health Launches Caregiver Companion App

What You Should Know: – Laguna Health, an AI-powered care management platform launched its Caregiver Companion app, a fully-digital care experience for caregivers supporting patients throughout their post-hospital care journeys. – The app provides caregivers with greater visibility into the

September 25, 2023

John Snow Labs Launches No-Code Generative AI Lab

What You Should Know: – John Snow Labs launches Generative AI Lab, a first-of-its-kind platform empowering healthcare professionals, even those without coding experience, to harness

April 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.